Abstract
Family and twin studies as well as animal studies indicate that gallstone disease is, in part, genetically determined. Recently new single gene defects have been identified in specific patients with cholesterol and pigment gallstones. Examples include low phospholipid-associated cholelithiasis due to mutations of the gene encoding the hepatocanalicular phosphatidylcholine transporter, and pigment stones in association with mutations of the ileal bile salt transporter gene. Here we summarize the evidence for common genetic determinants of human gallstone disease in general and provide an inventory of human lithogenic genes. The precise understanding of such genes and their molecular mechanisms will establish new targets for rational drug design for this exceptionally prevalent and economically significant digestive disease.
Keywords: cholecystolithiasis, micelles, phospholipid vesicles, symptomatic gallbladder disease, abc transporter b, p-glycoprotein, knockout mice, orthologous, murine abcb gene
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title: The Genetic Background of Cholesterol Gallstone Formation: An Inventory of Human Lithogenic Genes
Volume: 5 Issue: 2
Author(s): Frank Lammert and Siegfried Matern
Affiliation:
Keywords: cholecystolithiasis, micelles, phospholipid vesicles, symptomatic gallbladder disease, abc transporter b, p-glycoprotein, knockout mice, orthologous, murine abcb gene
Abstract: Family and twin studies as well as animal studies indicate that gallstone disease is, in part, genetically determined. Recently new single gene defects have been identified in specific patients with cholesterol and pigment gallstones. Examples include low phospholipid-associated cholelithiasis due to mutations of the gene encoding the hepatocanalicular phosphatidylcholine transporter, and pigment stones in association with mutations of the ileal bile salt transporter gene. Here we summarize the evidence for common genetic determinants of human gallstone disease in general and provide an inventory of human lithogenic genes. The precise understanding of such genes and their molecular mechanisms will establish new targets for rational drug design for this exceptionally prevalent and economically significant digestive disease.
Export Options
About this article
Cite this article as:
Lammert Frank and Matern Siegfried, The Genetic Background of Cholesterol Gallstone Formation: An Inventory of Human Lithogenic Genes, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2005; 5(2) . https://dx.doi.org/10.2174/1568005310505020163
DOI https://dx.doi.org/10.2174/1568005310505020163 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
Related Articles
-
Pyridines and Imidazopyridines with Medicinal Significance
Current Topics in Medicinal Chemistry Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention
Current Vascular Pharmacology A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
Current Pharmaceutical Design Clopidogrel Generic Formulations in the Era of New Antiplatelets: A Systematic Review
Current Vascular Pharmacology The Complement Cascade: New Avenues in Stroke Therapy
Current Vascular Pharmacology Diabetes, Sexual Dysfunction and Therapeutic Exercise: A 20 Year Review
Current Diabetes Reviews Organophosphorus Compounds: Intervention in Mechanisms of Signal Transduction Relevant to Proliferative, Immunological and Circulatory Disorders
Current Medicinal Chemistry Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma
Current Cancer Drug Targets Recurrent Gastrointestinal Bleeding in a Patient with Eisenmenger Syndrome Using Bosentan
Current Drug Safety From Gene to Epigene-Based Therapies Targeting the Vascular Endothelium
Current Vascular Pharmacology Mechanical Thrombectomy in Acute Ischaemic Stroke: A Review of the Literature, Clinical Effectiveness and Future Use
CNS & Neurological Disorders - Drug Targets Chemical Biology: Past, Present and Future
Current Chemical Biology The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease
Current Pharmaceutical Design Obesity and Pregnancy
Current Women`s Health Reviews Caring for Children with Medical Complexity: Definitions, Challenges and Solutions
Current Pediatric Reviews Cardioprotection Acquired Through Exercise: The Role of Ischemic Preconditioning
Current Cardiology Reviews Gestational Programming of Offspring Obesity: A Potential Contributor to Alzheimers Disease
Current Alzheimer Research Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Recent Patents on Anti-Cancer Drug Discovery Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews